Evidence map›Paper›PMID 25393129›Full record

ArticleJAMA ophthalmology2015

Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine.

Cynthia Owsley, Gerald McGwin, David J Lee, Byron L Lam, David S Friedman, Emily W Gower, Julia A Haller, Lisa A Hark, Jinan Saaddine, Innovative Network for Sight (INSIGHT) Research Group

Erratum issuedOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in JAMA ophthalmology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Effect of Accessible Nonmydriatic Retinal Imaging on Diabetic Retinopathy Surveillance Rates.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Teleophthalmology Using Remote Retinal Imaging During the COVID-19 Pandemic.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 1 country.

Cynthia OwsleyDepartment of Ophthalmology, School of Medicine, University of Alabama at Birmingham.
Gerald McGwinDepartment of Ophthalmology, School of Medicine, University of Alabama at Birmingham2Department of Epidemiology, School of Public Health, University of Alabama at Birmingham.
David J LeeDepartment of Public Health Sciences, Miller School of Medicine, University of Miami, Miami, Florida.
Byron L LamBascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida.
David S FriedmanWilmer Eye Institute, Dana Center for Preventive Ophthalmology, The Johns Hopkins School of Medicine, Baltimore, Maryland.
Emily W GowerWilmer Eye Institute, Dana Center for Preventive Ophthalmology, The Johns Hopkins School of Medicine, Baltimore, Maryland6Department of Epidemiology, Wake Forest School of Medicine, Winston-Salem, North Carolina7Department of Ophthalmology, Wake Forest Sc.
Julia A HallerWills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Lisa A HarkWills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
Jinan SaaddineVision Health Initiative, Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, Georgia.
Innovative Network for Sight (INSIGHT) Research Group
University of Alabama at Birmingham · USUniversity of Miami · USCenters for Disease Control and Prevention · USJohns Hopkins University · USThomas Jefferson University · USWake Forest University · USWills Eye Hospital · US

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Stuart J Frank · 2013 to 2026
$19.5M
Overcoming Barriers in Vision Care Utilization of African Americans with DiabetesU58DP002655 · DP · WILLS EYE HEALTH SYSTEM · PI HALLER, JULIA A · 2010 to 2015
$1.3M
Improving Access to and Quality of Eye Care in an At-Risk, Underserved PopulationU58DP002651 · DP · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OWSLEY, CYNTHIA · 2010 to 2015
$1.3M
University of Miami Vision Loss Prevention Translational Research CenterU58DP002652 · DP · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LEE, DAVID J · 2010 to 2015
$1.3M
Johns Hopkins Healthy Eyes Translational Research CenterU58DP002653 · DP · JOHNS HOPKINS UNIVERSITY · PI FRIEDMAN, DAVID S · 2010 to 2015
$1.3M
ACL HHS U58DP002652ACL HHS U58DP002653NCCDPHP CDC HHS 5U58DP002651NCCDPHP CDC HHS 5U58DP002652NCCDPHP CDC HHS 5U58DP002653NCCDPHP CDC HHS 5U58DP002655NCCDPHP CDC HHS U01 DP005127NCCDPHP CDC HHS U58 DP002651NCCDPHP CDC HHS U58 DP002652NCCDPHP CDC HHS U58 DP002653NCCDPHP CDC HHS U58 DP002655NIDDK NIH HHS P30 DK079626
6 · The paper itself

Abstract

importanceThe use of a nonmydriatic camera for retinal imaging combined with the remote evaluation of images at a telemedicine reading center has been advanced as a strategy for diabetic retinopathy (DR) screening, particularly among patients with diabetes mellitus from ethnic/racial minority populations with low utilization of eye care.

objectiveTo examine the rate and types of DR identified through a telemedicine screening program using a nonmydriatic camera, as well as the rate of other ocular findings. DESIGN, SETTING, AND

participantsA cross-sectional study (Innovative Network for Sight [INSIGHT]) was conducted at 4 urban clinic or pharmacy settings in the United States serving predominantly ethnic/racial minority and uninsured persons with diabetes. Participants included persons aged 18 years or older who had type 1 or 2 diabetes mellitus and presented to the community-based settings. MAIN OUTCOMES AND MEASURES: The percentage of DR detection, including type of DR, and the percentage of detection of other ocular findings.

resultsA total of 1894 persons participated in the INSIGHT screening program across sites, with 21.7% having DR in at least 1 eye. The most common type of DR was background DR, which was present in 94.1% of all participants with DR. Almost half (44.2%) of the sample screened had ocular findings other than DR; 30.7% of the other ocular findings were cataract. CONCLUSIONS AND RELEVANCE: In a DR telemedicine screening program in urban clinic or pharmacy settings in the United States serving predominantly ethnic/racial minority populations, DR was identified on screening in approximately 1 in 5 persons with diabetes. The vast majority of DR was background, indicating high public health potential for intervention in the earliest phases of DR when treatment can prevent vision loss. Other ocular conditions were detected at a high rate, a collateral benefit of DR screening programs that may be underappreciated.

Indexed as

Diagnostic Techniques, OphthalmologicalMinority GroupsAdultCross-Sectional StudiesDiabetic RetinopathyDisease ProgressionFemaleFollow-Up StudiesGlycated HemoglobinHumansMaleMass ScreeningMiddle AgedPrevalencePrognosisRetrospective StudiesGlycated Hemoglobin

Identifiers

PMID25393129
PMCPMC4479273
OpenAlexW2129663296

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.